Community-acquired Pneumonia Clinical Trials

31 recruitingLast updated: June 18, 2026

There are 31 actively recruiting community-acquired pneumonia clinical trials across 46 countries. Studies span Phase 3, Not Applicable, Phase 4, Phase 2. Top locations include Hamilton, Ontario, Canada, Ottawa, Ontario, Canada, Hamburg, Germany. Updated daily from ClinicalTrials.gov.


Community-acquired Pneumonia Trials at a Glance

31 actively recruiting trials for community-acquired pneumonia are listed on ClinicalTrialsFinder across 6 cities in 46 countries. The largest study group is Phase 3 with 10 trials, with the heaviest enrollment activity in Hamilton, Ottawa, and Hamburg. Lead sponsors running community-acquired pneumonia studies include Jeffrey, Assiut University, and Assistance Publique - Hôpitaux de Paris.

Browse community-acquired pneumonia trials by phase

Treatments under study

About Community-acquired Pneumonia Clinical Trials

Looking for clinical trials for Community-acquired Pneumonia? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Community-acquired Pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Community-acquired Pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 3

Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia

InflammationCommunity-Acquired Pneumonia (CAP)Inflammation Plaque, Atherosclerotic
Ottawa Heart Institute Research Corporation168 enrolled1 locationNCT06710080
Recruiting

Epidemiological Study on Community Acquired Pneumonia

Community-acquired Pneumonia
Capnetz Stiftung20,000 enrolled1 locationNCT02139163
Recruiting
Not Applicable

Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy

Community-acquired Pneumonia
University Hospital, Tours1,078 enrolled38 locationsNCT06966310
Recruiting
Not Applicable

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

Community-acquired PneumoniaCommunity-Acquired Infections
Assiut University100 enrolled1 locationNCT06996834
Recruiting
Not Applicable

PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms

PneumoniaCommunity-Acquired Pneumonia (CAP)
Jeffrey Pernica698 enrolled6 locationsNCT07099976
Recruiting
Phase 3

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Community-acquired Pneumonia
University of Manitoba4,000 enrolled64 locationsNCT05848713
Recruiting
Phase 3

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Community-acquired Pneumonia
Nantes University Hospital326 enrolled19 locationsNCT06229288
Recruiting
Phase 3

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Community-acquired Pneumonia
Biotest590 enrolled147 locationsNCT05722938
Recruiting
Phase 4

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

Community-Acquired Pneumonia (CAP)
Copenhagen Respiratory Research1,600 enrolled14 locationsNCT06892197
Recruiting

Frailty and Outcomes in Older Emergency Department Patients With Pneumonia

Community-acquired PneumoniaFrailityHospitalizations
Ege University150 enrolled1 locationNCT07442656
Recruiting
Not Applicable

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

Community-acquired PneumoniaCommunity-Acquired Pneumonia (CAP)
Ann & Robert H Lurie Children's Hospital of Chicago2,000 enrolled4 locationsNCT06986148
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting
Phase 3

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

Community-acquired Pneumonia
Hellenic Institute for the Study of Sepsis330 enrolled24 locationsNCT06294600
Recruiting

The Fever Clinic Acute Respiratory Cohort

Influenza Like-illnessCommunity-acquired PneumoniaFebrile Illnesses+2 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Phase 3

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

Hospital-Acquired PneumoniaCommunity-acquired PneumoniaVentilator associated pneumonia+2 more
Jena University Hospital616 enrolled28 locationsNCT06134492
Recruiting

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

Community-Acquired Pneumonia (CAP)
Societa Italiana di Pneumologia1,298 enrolled1 locationNCT06755814
Recruiting
Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Community-acquired Pneumonia
Mayo Clinic1,120 enrolled5 locationsNCT07164131
Recruiting
Phase 4

The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)

Community-acquired Pneumonia
Research Unit for General Practice in Aalborg600 enrolled1 locationNCT06295120
Recruiting
Phase 2

Efficacy and Safety of SR1375 in Adult Patients With CAP

Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.240 enrolled29 locationsNCT06577558
Recruiting
Not Applicable

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

COPD Exacerbation AcuteCommunity-acquired Pneumonia
University of Vermont8 enrolled1 locationNCT05452226